- Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease
-
Lopez-Millan B, Diaz de la Guardia R, Roca-Ho H, GarcÃa-Herrero CM, Lavoie JR, Rosu-Myles M, Gonzalez-Rey E, O'Valle F, Criado G, Delgado M, Menendez P
- KMID: 2375020
- Exp Mol Med.
- 2017 Feb;49(2):e290.
- doi: 10.1038/emm.2016.143
Thalidomide is an immunomodulatory drug (IMiD) with proven therapeutic action in several autoimmune/inflammatory diseases; however, its inherent high toxicity has led to the development of more powerful and safer thalidomide... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Molecular Study of the Extracellular Matrix Protein 1 Gene in a Spanish Family with Lipoid Proteinosis
-
Mondejar R, Garcia-Moreno JM, Rubio R, Solano F, Delgado M, Garcia-Bravo B, Rios-Martin JJ, Martinez-Mir A, Lucas M
- KMID: 2400178
- J Clin Neurol.
- 2014 Jan;10(1):64-68.
BACKGROUND: Lipoid proteinosis (LP) is a rare autosomal recessive disorder characterized by a hoarse voice, variable scarring, and infiltration of the skin and mucosa. This disease is associated with mutations... -
- CITED
-
- Close
- SHARE
-
- Close
